- Patent Title: Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of HIF-2A pathway inhibition, and induction of ferroptosis
-
Application No.: US16791148Application Date: 2020-02-14
-
Publication No.: US11447482B1Publication Date: 2022-09-20
- Inventor: Xiaohui Liu , Mei Yee Koh
- Applicant: KUDA Therapeutics, Inc.
- Applicant Address: US UT Salt Lake City
- Assignee: KUDA Therapeutics, Inc.
- Current Assignee: KUDA Therapeutics, Inc.
- Current Assignee Address: US UT Salt Lake City
- Agency: Workman Nydegger
- Main IPC: C07D417/12
- IPC: C07D417/12 ; C07D471/04 ; A61P35/00 ; C07D487/04 ; C07D513/04 ; C07D498/04

Abstract:
Novel substituted imidazopyridine and oxazolopyridine compounds that are useful as inhibitors of HIF-2α and inducers of ferroptosis through perturbations in iron metabolism, synthetic methods for making said compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions to treat disorders associated with dysfunction of HIF-2α or iron metabolism.
Public/Granted literature
Information query